Amina Ghouzlani
Overview
Explore the profile of Amina Ghouzlani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harmak Z, Kone A, Ghouzlani A, Ghazi B, Badou A
Immune Netw
. 2025 Jan;
24(6):e40.
PMID: 39801738
The human body contains a diverse array of microorganisms, which exert a significant impact on various physiological processes, including immunity, and can significantly influence susceptibility to various diseases such as...
2.
Naji O, Ghouzlani A, Rafii S, Sadiqi R, Kone A, Harmak Z, et al.
Front Immunol
. 2024 Nov;
15:1399754.
PMID: 39507526
The interplay between immune cells and malignant cells represents an essential chapter in the eradication of breast cancer. This widely distributed and diverse form of cancer represents a major threat...
3.
Kone A, Ghouzlani A, Qandouci A, El Imane Issam Salah N, Bakoukou Y, Lakhdar A, et al.
Front Immunol
. 2024 Jun;
15:1397486.
PMID: 38863709
Introduction: Gliomas represent the most prevalent and aggressive tumors within the central nervous system. Despite the current standard treatments, the median survival time for glioblastoma patients remains dismal, hovering around...
4.
Iske J, El Fatimy R, Nian Y, Ghouzlani A, Eskandari S, Rodriguez Cetina Biefer H, et al.
Elife
. 2024 Feb;
12.
PMID: 38372712
Septic shock is characterized by an excessive inflammatory response depicted in a cytokine storm that results from invasive bacterial, fungi, protozoa, and viral infections. Non-canonical inflammasome activation is crucial in...
5.
Miftah H, Naji O, Ssi S, Ghouzlani A, Lakhdar A, Badou A
Front Immunol
. 2023 Aug;
14:1139268.
PMID: 37575237
Intoroduction: Nuclear receptor subfamily 2 group F member 6 (NR2F6) is a promising checkpoint target for cancer immunotherapy. However, there has been no investigation of NR2F6 in glioma. Our study...
6.
Rafii S, Kandoussi S, Ghouzlani A, Naji O, Reddy K, Sadiqi R, et al.
Front Oncol
. 2023 Jun;
13:1135430.
PMID: 37274252
Gliomas are considered one of the most malignant cancers in the body. Despite current therapies, including surgery, chemotherapy, and radiotherapy, these tumors usually recur with more aggressive and resistant phenotypes....
7.
Rafii S, Ghouzlani A, Naji O, Ssi S, Kandoussi S, Lakhdar A, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047660
Gliomas are considered one of the most malignant tumors in the body. The immune system has the ability to control the initiation and development of tumors, including gliomas. Thus, immune...
8.
Ghazi B, El Ghanmi A, Kandoussi S, Ghouzlani A, Badou A
Front Immunol
. 2022 Dec;
13:978195.
PMID: 36458008
Chimeric antigen receptor (CAR) T-cells represent a new genetically engineered cell-based immunotherapy tool against cancer. The use of CAR T-cells has revolutionized the therapeutic approach for hematological malignancies. Unfortunately, there...
9.
Ghouzlani A, Lakhdar A, Rafii S, Karkouri M, Badou A
Sci Rep
. 2021 Nov;
11(1):21504.
PMID: 34728682
In human gliomas, anti-tumor T cell responses are inhibited through induction of local and systemic immunosuppression. Immune checkpoint blockade is proving to be a success in several types of cancers....
10.
Ghouzlani A, Kandoussi S, Tall M, Reddy K, Rafii S, Badou A
Front Immunol
. 2021 Jul;
12:679425.
PMID: 34305910
Gliomas are the most common primary brain tumors in adults. Despite the fact that they are relatively rare, they cause significant morbidity and mortality. High-grade gliomas or glioblastomas are rapidly...